Grand Pharmaceutical Group Limited — Proxy Solicitation & Information Statement 2017

Apr 27, 2017

==> picture [119 x 53] intentionally omitted <==

China Grand Pharmaceutical and Healthcare Holdings Limited 遠大醫藥健康控股有限公司[*]

(Incorporated in Bermuda with limited liability)

(Stock Code: 00512)

Proxy Form

For the annual general meeting to be held on 9 June 2017 or any adjournment thereof

I/We [ (Note 1)] of

being the registered holder(s) of [(Note 2)] ordinary shares of HK$0.01 each in the capital of China Grand Pharmaceutical and Healthcare Holdings Limited (the “Company”), HEREBY APPOINT the chairman of the Meeting or [(Note 3) ] or failing him/her of

ordinary shares of HK$0.01 each in the capital

as my/our proxy to attend and vote for me/us and on my/our behalf at the annual general meeting of the Company (the “Meeting”) to be held at Unit 3302, The Centre, 99 Queen’s Road Central, Hong Kong on 9 June 2017 at 11:00 a.m. and at any adjournment thereof in respect of the resolutions as indicated below [(Note 4)] or, if no such indication is given, as my/our proxy thinks fit.

	ORDINARY RESOLUTIONS (Note 5)	FOR	AGAINST
1.	To adopt the audited financial statements together with the report of thedirectors and the report of the auditors for the year ended 31 December 2016.
2.	(a) To re-elect Dr. Shao Yan as an executive director.
	(b) To re-elect Ms. So Tosi Wan, Winnie as an independent non-executivedirector.
	(c) To re-elect Dr. Pei Geng as an independent non-executive director.
	(d) To re-elect Dr. Niu Zhanqi as an executive director.
	(e) To authorise the board of directors to fix the directors’ remuneration.
3.	To re-appoint HLB Hodgson Impey Cheng Limited as auditors to hold officeuntil the conclusion of the next annual general meeting of the Company and toauthorise the board of directors to fix their remuneration.
4.	To grant a general mandate to the board of directors to issue shares.

Dated this

day of

2017

Signature:

Notes:

1. Full name(s) and address(es) to be inserted in BLOCK CAPITALS.

2. Please insert the number of shares registered in your name(s). If no number is inserted, this proxy form will be deemed to relate to all the shares of the Company registered in your name(s).

3. If any proxy other than the chairman of the Meeting is preferred, strike out “the chairman of the Meeting or” and insert the name and address of the proxy desired in the space provided. The proxy need not be a shareholder of the Company but must attend the Meeting in person to represent you.

4. If you wish to vote for a resolution, place a tick “✓” in the column marked “ For ”. If you wish to vote against a resolution, place a tick “✓” in the column marked “ Against ”. If no indication is given, the proxy will vote or abstain at his/her discretion.

5. The full text of the resolutions is set out in the notice of the Meeting dated 28 April 2017.

6. Corporations must execute this proxy form under common seal or under the hand of an attorney or a duly authorised officer. If a legal representative is appointed to attend the Meeting, such legal representative shall produce his/her own identity paper and a certified true copy of the resolution of the board of directors or other governing body of the corporation appointing the legal representative.

7. To be valid, this proxy form, together with any power of attorney or other authority (if any) under which it is signed or a certified copy of such power of attorney, must be deposited at the Company’s branch registrar in Hong Kong, Computershare Hong Kong Investor Services Limited at Shops 1712-1716, 17th Floor, Hopewell Centre, 183 Queen’s Road East, Wanchai, Hong Kong not less than 48 hours before the time appointed for holding the Meeting or adjournment thereof.

8. Completion and delivery of this proxy form will not preclude you from attending and voting at the Meeting if you so wish.

• For identification purpose only